Protein FDR Confidence: Combined	Accession	Description	Exp. q-value: Combined	Sum PEP Score	Coverage [%]	# Peptides	# PSMs	# Unique Peptides	# AAs	MW [kDa]	calc. pI	Abundance Ratio: (DKO) / (WT)	Abundance Ratio: (SKO) / (WT)	Abundance Ratio (log2): (DKO) / (WT)	Abundance Ratio (log2): (SKO) / (WT)	Abundance Ratio P-Value: (DKO) / (WT)	Abundance Ratio P-Value: (SKO) / (WT)	Abundance Ratio Adj. P-Value: (DKO) / (WT)	Abundance Ratio Adj. P-Value: (SKO) / (WT)	Abundances (Grouped): DKO	Abundances (Grouped): SKO	Abundances (Grouped): WT	Abundances (Grouped) CV [%]: DKO	Abundances (Grouped) CV [%]: SKO	Abundances (Grouped) CV [%]: WT	Abundances (Scaled): F1: 127C, Sample, DKO, 1	Abundances (Scaled): F1: 128C, Sample, DKO, 2	Abundances (Scaled): F1: 129C, Sample, DKO, 3	Abundances (Scaled): F1: 130C, Sample, DKO, 4	Abundances (Scaled): F1: 129N, Sample, SKO, 1	Abundances (Scaled): F1: 130N, Sample, SKO, 2	Abundances (Scaled): F1: 131, Sample, SKO, 3	Abundances (Scaled): F1: 126, Sample, WT, 1	Abundances (Scaled): F1: 127N, Sample, WT, 2	Abundances (Scaled): F1: 128N, Sample, WT, 3	Abundances (Normalized): F1: 127C, Sample, DKO, 1	Abundances (Normalized): F1: 128C, Sample, DKO, 2	Abundances (Normalized): F1: 129C, Sample, DKO, 3	Abundances (Normalized): F1: 130C, Sample, DKO, 4	Abundances (Normalized): F1: 129N, Sample, SKO, 1	Abundances (Normalized): F1: 130N, Sample, SKO, 2	Abundances (Normalized): F1: 131, Sample, SKO, 3	Abundances (Normalized): F1: 126, Sample, WT, 1	Abundances (Normalized): F1: 127N, Sample, WT, 2	Abundances (Normalized): F1: 128N, Sample, WT, 3	Abundance: F1: 127C, Sample, DKO, 1	Abundance: F1: 128C, Sample, DKO, 2	Abundance: F1: 129C, Sample, DKO, 3	Abundance: F1: 130C, Sample, DKO, 4	Abundance: F1: 129N, Sample, SKO, 1	Abundance: F1: 130N, Sample, SKO, 2	Abundance: F1: 131, Sample, SKO, 3	Abundance: F1: 126, Sample, WT, 1	Abundance: F1: 127N, Sample, WT, 2	Abundance: F1: 128N, Sample, WT, 3	Abundances Count: F1: 127C, Sample, DKO, 1	Abundances Count: F1: 128C, Sample, DKO, 2	Abundances Count: F1: 129C, Sample, DKO, 3	Abundances Count: F1: 130C, Sample, DKO, 4	Abundances Count: F1: 129N, Sample, SKO, 1	Abundances Count: F1: 130N, Sample, SKO, 2	Abundances Count: F1: 131, Sample, SKO, 3	Abundances Count: F1: 126, Sample, WT, 1	Abundances Count: F1: 127N, Sample, WT, 2	Abundances Count: F1: 128N, Sample, WT, 3	Biological Process	Cellular Component	Molecular Function	Pfam IDs	Entrez Gene ID	Gene Symbol	Chromosome	Reactome Pathways	Ensembl Gene ID	KEGG Pathways	WikiPathways	# Razor Peptides	Modifications
High	P61982	14-3-3 protein gamma OS=Mus musculus OX=10090 GN=Ywhag PE=1 SV=2	0	147.892	62	17	81	11	247	28.3	4.89	0.578	0.796	-0.79	-0.33	0.564412016	0.341524877	0.999945597	0.969660583	73.1	100.6	126.4	6.2	2	8.76	68.2	73.6	78.4	77.3	100.3	103.8	104	120.6	143.5	130.4	2736.3	2952.2	3147.5	3101.3	4026.2	4164.3	4173.7	4839.5	5761.2	5232.3	2130.7	2541.2	2803.4	2682.4	3759.8	3392	4173.7	4423.4	5077.2	4826.6	19	19	19	19	19	19	19	19	19	19	metabolic process;regulation of biological process;response to stimulus;transport	cytoplasm;cytosol;membrane	catalytic activity;protein binding;RNA binding	Pf00244	22628	Ywhag	5	Translocation of GLUT4 to the plasma membrane; Anchoring of the basal body to the plasma membrane; Activation of BAD and translocation to mitochondria ; AURKA Activation by TPX2; RHO GTPases activate PKNs; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Regulation of PLK1 Activity at G2/M Transition; Recruitment of NuMA to mitotic centrosomes; TP53 Regulates Metabolic Genes; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	ENSMUSG00000051391.9	Epstein-Barr virus infection; Hippo signaling pathway; Oocyte meiosis; Cell cycle; PI3K-Akt signaling pathway; Viral carcinogenesis	TNF-alpha NF-kB Signaling Pathway; Myometrial Relaxation and Contraction Pathways; Calcium Regulation in the Cardiac Cell	5

[View entry in the full dataset]